0 CHECKOUT

Research Update: Sweetheart Cup Co. Inc. Dec 03

  • ID: 2024912
  • December 2003
  • Standard & Poors

FEATURED COMPANIES

  • Fonda Group Inc. (The)
  • International Paper Co.
  • Sweetheart Cup Co. Inc.
  • Sweetheart Holdings Inc.
  • MORE

Abstract
On Dec. 18, 2003, Standard & Poor's Ratings Services raised its ratings on Owings Mills, Md.-based Sweetheart Cup Co. Inc. (see list below) and assigned its 'CCC' senior secured debt rating to the company's offering of $100 million 9.5% senior secured notes due 2007, issued under Rule 144A with registration rights. The outlook is stable. The upgrade follows the company's closing on debt refinancing that significantly improves its debt maturity profile. There are now no major debt maturities before 2007. Total debt outstanding as of Sept. 30, 2003 (including capitalized operating leases and parent-company obligations), was nearly $800 million. If this financing had not been completed by year end, Sweetheart's bank credit facility would have matured on Dec. 31, 2003....

Companies mentioned in this report are:
- Sweetheart Cup Co. Inc.
- International Paper Co.
- Sweetheart Holdings Inc.
- Fonda Group Inc. (The)

Action: Various Rating Actions

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. READ MORE >

Note: Product cover images may vary from those shown

- Sweetheart Cup Co. Inc.
- International Paper Co.
- Sweetheart Holdings Inc.
- Fonda Group Inc. (The)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.